vs
Side-by-side financial comparison of Nutex Health, Inc. (NUTX) and Perella Weinberg Partners (PWP). Click either name above to swap in a different company.
Perella Weinberg Partners is the larger business by last-quarter revenue ($219.2M vs $151.7M, roughly 1.4× Nutex Health, Inc.). Nutex Health, Inc. runs the higher net margin — 7.8% vs 6.3%, a 1.5% gap on every dollar of revenue. On growth, Perella Weinberg Partners posted the faster year-over-year revenue change (-2.9% vs -41.1%). Nutex Health, Inc. produced more free cash flow last quarter ($69.0M vs $30.5M). Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs 46.5%).
Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.
PJT Partners, Inc. is a global advisory-focused investment bank, founded in October 2015 as part of The Blackstone Group's spin-off of its financial and strategic advisory services businesses.
NUTX vs PWP — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $151.7M | $219.2M |
| Net Profit | $11.8M | $13.8M |
| Gross Margin | 30.4% | — |
| Operating Margin | 20.4% | 8.5% |
| Net Margin | 7.8% | 6.3% |
| Revenue YoY | -41.1% | -2.9% |
| Net Profit YoY | -80.8% | — |
| EPS (diluted) | $2.34 | $0.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $151.7M | $219.2M | ||
| Q3 25 | $267.8M | $164.6M | ||
| Q2 25 | $244.0M | $155.3M | ||
| Q1 25 | $211.8M | $211.8M | ||
| Q4 24 | $257.6M | $225.7M | ||
| Q3 24 | $78.8M | $278.2M | ||
| Q2 24 | $76.1M | $272.0M | ||
| Q1 24 | $67.5M | $102.1M |
| Q4 25 | $11.8M | $13.8M | ||
| Q3 25 | $55.4M | $6.0M | ||
| Q2 25 | $-17.7M | $2.7M | ||
| Q1 25 | $21.2M | $17.3M | ||
| Q4 24 | $61.6M | — | ||
| Q3 24 | $-8.8M | $16.4M | ||
| Q2 24 | $-364.0K | $-66.0M | ||
| Q1 24 | $-364.0K | $-35.8M |
| Q4 25 | 30.4% | — | ||
| Q3 25 | 57.8% | — | ||
| Q2 25 | 51.2% | — | ||
| Q1 25 | 55.9% | — | ||
| Q4 24 | 55.0% | — | ||
| Q3 24 | 27.8% | — | ||
| Q2 24 | 29.7% | — | ||
| Q1 24 | 15.1% | — |
| Q4 25 | 20.4% | 8.5% | ||
| Q3 25 | 48.7% | 5.4% | ||
| Q2 25 | 13.8% | 5.8% | ||
| Q1 25 | 38.1% | 5.5% | ||
| Q4 24 | 44.4% | — | ||
| Q3 24 | 12.3% | 12.9% | ||
| Q2 24 | 7.0% | -30.2% | ||
| Q1 24 | 2.1% | -52.4% |
| Q4 25 | 7.8% | 6.3% | ||
| Q3 25 | 20.7% | 3.6% | ||
| Q2 25 | -7.3% | 1.8% | ||
| Q1 25 | 10.0% | 8.2% | ||
| Q4 24 | 23.9% | — | ||
| Q3 24 | -11.2% | 5.9% | ||
| Q2 24 | -0.5% | -24.3% | ||
| Q1 24 | -0.5% | -35.1% |
| Q4 25 | $2.34 | $0.11 | ||
| Q3 25 | $7.76 | $0.08 | ||
| Q2 25 | $-2.95 | $0.04 | ||
| Q1 25 | $3.33 | $0.24 | ||
| Q4 24 | $11.56 | — | ||
| Q3 24 | $-1.72 | $0.24 | ||
| Q2 24 | $-0.07 | $-1.21 | ||
| Q1 24 | $-0.08 | $-0.91 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $185.6M | $255.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $329.4M | $-127.4M |
| Total Assets | $918.5M | $797.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $185.6M | $255.9M | ||
| Q3 25 | $166.0M | $185.5M | ||
| Q2 25 | $96.7M | $145.0M | ||
| Q1 25 | $84.7M | $111.2M | ||
| Q4 24 | $40.6M | $407.4M | ||
| Q3 24 | $46.9M | $335.1M | ||
| Q2 24 | $40.8M | $185.3M | ||
| Q1 24 | $30.0M | $156.7M |
| Q4 25 | $329.4M | $-127.4M | ||
| Q3 25 | $317.2M | $-302.4M | ||
| Q2 25 | $235.3M | $-318.4M | ||
| Q1 25 | $176.9M | $-323.1M | ||
| Q4 24 | $132.4M | $-421.4M | ||
| Q3 24 | $60.4M | $-360.8M | ||
| Q2 24 | $62.7M | $-283.0M | ||
| Q1 24 | $63.0M | $161.9M |
| Q4 25 | $918.5M | $797.6M | ||
| Q3 25 | $964.5M | $650.2M | ||
| Q2 25 | $841.0M | $606.7M | ||
| Q1 25 | $761.9M | $570.5M | ||
| Q4 24 | $655.3M | $876.8M | ||
| Q3 24 | $438.5M | $810.9M | ||
| Q2 24 | $422.4M | $645.5M | ||
| Q1 24 | $404.3M | $583.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $70.4M | $34.8M |
| Free Cash FlowOCF − Capex | $69.0M | $30.5M |
| FCF MarginFCF / Revenue | 45.5% | 13.9% |
| Capex IntensityCapex / Revenue | 0.9% | 2.0% |
| Cash ConversionOCF / Net Profit | 5.95× | 2.52× |
| TTM Free Cash FlowTrailing 4 quarters | $245.6M | $-34.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $70.4M | $34.8M | ||
| Q3 25 | $99.5M | $59.2M | ||
| Q2 25 | $27.3M | $56.1M | ||
| Q1 25 | $51.0M | $-176.5M | ||
| Q4 24 | $54.0K | $223.4M | ||
| Q3 24 | $6.8M | $200.3M | ||
| Q2 24 | $13.3M | $90.0M | ||
| Q1 24 | $3.1M | $-206.3M |
| Q4 25 | $69.0M | $30.5M | ||
| Q3 25 | $99.2M | $57.6M | ||
| Q2 25 | $26.5M | $55.3M | ||
| Q1 25 | $50.9M | $-177.6M | ||
| Q4 24 | $-341.0K | $207.0M | ||
| Q3 24 | $6.2M | $199.3M | ||
| Q2 24 | $12.7M | $83.7M | ||
| Q1 24 | $2.3M | $-214.8M |
| Q4 25 | 45.5% | 13.9% | ||
| Q3 25 | 37.0% | 35.0% | ||
| Q2 25 | 10.9% | 35.6% | ||
| Q1 25 | 24.0% | -83.8% | ||
| Q4 24 | -0.1% | 91.7% | ||
| Q3 24 | 7.8% | 71.6% | ||
| Q2 24 | 16.7% | 30.8% | ||
| Q1 24 | 3.4% | -210.3% |
| Q4 25 | 0.9% | 2.0% | ||
| Q3 25 | 0.1% | 0.9% | ||
| Q2 25 | 0.3% | 0.5% | ||
| Q1 25 | 0.0% | 0.5% | ||
| Q4 24 | 0.2% | 7.3% | ||
| Q3 24 | 0.8% | 0.4% | ||
| Q2 24 | 0.7% | 2.3% | ||
| Q1 24 | 1.1% | 8.3% |
| Q4 25 | 5.95× | 2.52× | ||
| Q3 25 | 1.80× | 9.85× | ||
| Q2 25 | — | 20.50× | ||
| Q1 25 | 2.40× | -10.18× | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | — | 12.23× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
PWP
Segment breakdown not available.
